These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32164367)

  • 21. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
    Mbah GE; Ayiseh RB; Cho-Ngwa F
    BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus.
    Remme J; Baker RH; De Sole G; Dadzie KY; Walsh JF; Adams MA; Alley ES; Avissey HS
    Trop Med Parasitol; 1989 Sep; 40(3):367-74. PubMed ID: 2617046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of onchocerciasis-associated epilepsy in villages in Maridi County, Republic of South Sudan.
    Colebunders R; Abd-Elfarag G; Carter JY; Olore PC; Puok K; Menon S; Fodjo Siewe JN; Bhattacharyya S; Ojok M; Lako R; Logora MY
    Seizure; 2018 Nov; 62():108-115. PubMed ID: 30340162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of three-month doses of ivermectin on adult Onchocerca volvulus.
    Duke BO; Zea-Flores G; Castro J; Cupp EW; Munoz B
    Am J Trop Med Hyg; 1992 Feb; 46(2):189-94. PubMed ID: 1539754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical presentations of onchocerciasis-associated epilepsy (OAE) in Cameroon.
    Siewe JFN; Ngarka L; Tatah G; Mengnjo MK; Nfor LN; Chokote ES; Boullé C; Nkouonlack C; Dema F; Nkoro GA; Njamnshi WY; Tabah EN; Zoung-Kanyi Bissek AC; Colebunders R; Njamnshi AK
    Epilepsy Behav; 2019 Jan; 90():70-78. PubMed ID: 30513438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimes of MK-933 (ivermectin) in human onchocerciasis.
    Awadzi K; Dadzie KY; Shulz-Key H; Haddock DR; Gilles HM; Aziz MA
    Ann Trop Med Parasitol; 1985 Feb; 79(1):63-78. PubMed ID: 3838638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential Parasitic Causes of Epilepsy in an Onchocerciasis Endemic Area in the Ituri Province, Democratic Republic of Congo.
    Vieri MK; Mandro M; Cardellino CS; Orza P; Ronzoni N; Siewe Fodjo JN; Hotterbeekx A; Colebunders R
    Pathogens; 2021 Mar; 10(3):. PubMed ID: 33803565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
    Soboslay PT; Lüder CG; Hoffmann WH; Michaelis I; Helling G; Heuschkel C; Dreweck CM; Blanke CH; Pritze S; Banla M
    Clin Exp Immunol; 1994 May; 96(2):238-44. PubMed ID: 8187332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community perceptions of epilepsy and its treatment in an onchocerciasis endemic region in Ituri, Democratic Republic of Congo.
    Dolo H; Mandro M; Wonya'Rossi D; Ngave F; Fraeyman J; Siewe JN; Suykerbuyk P; Colebunders R
    Infect Dis Poverty; 2018 Dec; 7(1):115. PubMed ID: 30509330
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of epilepsy in two rural onchocerciasis endemic villages in the Mahenge area, Tanzania, after 20 years of community directed treatment with ivermectin.
    Mmbando BP; Suykerbuyk P; Mnacho M; Kakorozya A; Matuja W; Hendy A; Greter H; Makunde WH; Colebunders R
    Infect Dis Poverty; 2018 Jun; 7(1):64. PubMed ID: 29921319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Onchocerca volvulus-specific antibody and cytokine responses in onchocerciasis patients after 16 years of repeated ivermectin therapy.
    Mai CS; Hamm DM; Banla M; Agossou A; Schulz-Key H; Heuschkel C; Soboslay PT
    Clin Exp Immunol; 2007 Mar; 147(3):504-12. PubMed ID: 17302900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.
    Awadzi K; Dadzie KY; Kläger S; Gilles HM
    Trop Med Parasitol; 1989 Sep; 40(3):361-6. PubMed ID: 2694315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin.
    Mössinger J; Schulz-Key H; Dietz K
    Trop Med Parasitol; 1988 Dec; 39(4):313-6. PubMed ID: 3067322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Onchocerca volvulus is not detected in the cerebrospinal fluid of persons with onchocerciasis-associated epilepsy.
    Hotterbeekx A; Raimon S; Abd-Elfarag G; Carter JY; Sebit W; Suliman A; Siewe Fodjo JN; De Witte P; Logora MY; Colebunders R; Kumar-Singh S
    Int J Infect Dis; 2020 Feb; 91():119-123. PubMed ID: 31786246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onchocerciasis control in the Democratic Republic of Congo (DRC): challenges in a post-war environment.
    Makenga Bof JC; Maketa V; Bakajika DK; Ntumba F; Mpunga D; Murdoch ME; Hopkins A; Noma MM; Zouré H; Tekle AH; Katabarwa MN; Lutumba P
    Trop Med Int Health; 2015 Jan; 20(1):48-62. PubMed ID: 25302560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in the prevalence and intensity of infection in Onchocerca volvulus microfilariae according to ethnicity and community after 8 years of ivermectin treatment on the island of Bioko, Equatorial Guinea.
    Mas J; Ascaso C; Escaramis G; Abellana R; Duran E; Sima A; Sánchez MJ; Nkogo PR; Nguema R; Untoria MD; Echeverria MA; Ardevol MM; de Jiménez Anta MT
    Trop Med Int Health; 2006 Jul; 11(7):1082-91. PubMed ID: 16827709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A community-based cross-sectional study of the epidemiology of onchocerciasis in unmapped villages for community directed treatment with ivermectin in Jimma Zone, southwestern Ethiopia.
    Dana D; Debalke S; Mekonnen Z; Kassahun W; Suleman S; Getahun K; Yewhalaw D
    BMC Public Health; 2015 Jul; 15():595. PubMed ID: 26130117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled prospective trial of the prophylactic effect of a single dose of ivermectin against Onchocerca volvulus.
    Boussinesq M; Chippaux JP
    Parasite; 2001 Sep; 8(3):255-9. PubMed ID: 11584757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.